The bill would bring dramatic changes to the Medicaid program, but it also has implications for drug prices, managed care ...

On Wednesday, U.S. Senators Catherine Cortez Masto (D-Nev.), Amy Klobuchar (D-Minn.), and Peter Welch (D- Vt.) introduced the ...

At least six organizations that claim to champion patient rights have deep financial and operational ties to Big Pharma and ...

The EO revives effort to link U.S. drug prices to those in peer countries, calling for voluntary industry action. Aggressive ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Tariffs on medications and raw ingredients impact global drug prices - hurting consumers and adding pressure to the healthcare system.

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...